Helicobacter Pylori Non-Invasive Testing Market
Helicobacter Pylori Non-Invasive Testing Market Study by Serology Tests, Stool Antigen Tests, and Urea Breath Tests from 2023 to 2033
Analysis of Helicobacter Pylori Non-Invasive Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Acronyms Used 3. Research Methodology 4. Executive Summary 5. Market Overview 5.1. Test Type Overview 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.3. Global Market Value (US$ Mn) Forecast, 2023-2033 5.4. Global Market Outlook 5.5. Key Industry Developments 5.6. Epidemiological Assessment of Helicobacter Pylori 5.7. New Non-invasive Test launches, by Market Players 5.8. Key Technological Advancements in Diagnostic Testing 6. Global Market Analysis, by Test Type 6.1. Introduction 6.2. Key Findings 6.3. Global Market Value Share Analysis, by Test Type 6.4. Global Market Value Forecast, by Test Type, 2023-2033 6.4.1. Serology Test 6.4.2. Stool Antigen Test (SAT) 6.4.3. Urea Breath Test (UBT) 6.4.4. Endoscopy Test Types 6.5. Global Market Attractiveness, by Test Type, 2023-2033 7. Global Market Analysis, by Test Method 7.1. Introduction 7.2. Key Findings 7.3. Market Value Share Analysis, by Test Method 7.4. Market Value Forecast, by Test Method, 2023-2033 7.4.1. Laboratory-based Tests 7.4.2. Point-of-Care Tests 7.5. Market Attractiveness, by Test Method 8. Global Market Analysis, by End-user 8.1. Introduction 8.2. Key Findings 8.3. Market Value Share Analysis, by End-user 8.4. Market Value Forecast, by End-user, 2023-2033 8.4.1. Hospitals 8.4.2. Clinics 8.4.3. Diagnostic Laboratories 8.5. Market Attractiveness, by End-user 9. Global Market Analysis and Forecasts, by Region 9.1. Introduction 9.2. Regional Outlook 9.3. Global Market Value Forecast, by Region, 2023-2033 9.3.1. North America 9.3.2. Europe 9.3.3. Asia Pacific 9.3.4. Latin America 9.3.5. Middle East & Africa 9.4. Global Market Attractiveness Analysis, by Region 10. North America Market Analysis 10.1. Key Findings 10.2. North America Market Value Forecast, by Country, 2023-2033 10.2.1. U.S. 10.2.2. Canada 10.3. North America Market Value Forecast, by Test Type, 2023-2033 10.3.1. Serology Test 10.3.2. Stool Antigen Test (SAT) 10.3.3. Urea Breath Test (UBT) 10.4. North America Market Value Forecast, by Test Method, 2023-2033 10.4.1. Laboratory-based Tests 10.4.2. Point-of-Care Tests 10.5. North America Market Value Forecast, by End-user, 2023-2033 10.5.1. Hospitals 10.5.2. Clinics 10.5.3. Diagnostic Laboratories 10.6. North America Market Attractiveness Analysis 10.6.1. By Country 10.6.2. By Test Type 10.6.3. By Test Method 10.6.4. By End-user 11. Europe Market Analysis 11.1. Key Findings 11.2. Europe Market Value Forecast by Country/Sub-region, 2023-2033 11.2.1. Germany 11.2.2. U.K. 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Rest of Europe 11.3. Europe Market Value Forecast, by Test Type, 2023-2033 11.3.1. Serology Test 11.3.2. Stool Antigen Test (SAT) 11.3.3. Urea Breath Test (UBT) 11.3.4. Endoscopy Test Types 11.4. Europe Market Value Forecast, by Test Method, 2023-2033 11.4.1. Laboratory-based Tests 11.4.2. Point-of-Care Tests 11.5. Europe Market Value Forecast, by End-user, 2023-2033 11.5.1. Hospitals 11.5.2. Clinics 11.5.3. Diagnostic Laboratories 11.6. Europe Market Attractiveness Analysis 11.6.1. By Country/Sub-region 11.6.2. By Test Type 11.6.3. By Test Method 11.6.4. By End-user 12. Asia Pacific Market Analysis 12.1. Key Findings 12.2. Asia Pacific Market Value Forecast by Country/Sub-region, 2023-2033 12.2.1. China 12.2.2. India 12.2.3. Japan 12.2.4. Australia 12.2.5. Rest of Asia Pacific 12.3. Asia Pacific Market Value Forecast, by Test Type, 2023-2033 12.3.1. Serology Test 12.3.2. Stool Antigen Test (SAT) 12.3.3. Urea Breath Test (UBT) 12.3.4. Endoscopy Test Types 12.4. Asia Pacific Market Value Forecast, by Test Method, 2023-2033 12.4.1. Laboratory-based Tests 12.4.2. Point-of-Care Tests 12.5. Asia Pacific Market Value Forecast, by End-user, 2023-2033 12.5.1. Hospitals 12.5.2. Clinics 12.5.3. Diagnostic Laboratories 12.6. Asia Pacific Market Attractiveness Analysis 12.6.1. By Country/Sub-region 12.6.2. By Test Type 12.6.3. By Test Method 12.6.4. By End-user 13. Latin America Market Analysis 13.1. Key Findings 13.2. Latin America Market Value Forecast by Country/Sub-region, 2023-2033 13.2.1. Brazil 13.2.2. Mexico 13.2.3. Rest of Latin America 13.3. Latin America Market Value Forecast, by Test Type, 2023-2033 13.3.1. Serology Test 13.3.2. Stool Antigen Test (SAT) 13.3.3. Urea Breath Test (UBT) 13.3.4. Endoscopy Test Types 13.4. Latin America Market Value Forecast, by Test Method, 2023-2033 13.4.1. Laboratory-based Tests 13.4.2. Point-of-Care Tests 13.5. Latin America Market Value Forecast, by End-user, 2023-2033 13.5.1. Hospitals 13.5.2. Clinics 13.5.3. Diagnostic Laboratories 13.6. Latin America Market Attractiveness Analysis 13.6.1. By Country/Sub-region 13.6.2. By Test Type 13.6.3. By Test Method 13.6.4. By End-user 14. Middle East & Africa Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Market Value Forecast by Country/Sub-region, 2023-2033 14.2.1. GCC Countries 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of Middle East & Africa 14.3. Middle East & Africa Market Value Forecast, by Test Type, 2023-2033 14.3.1. Serology Test 14.3.2. Stool Antigen Test (SAT) 14.3.3. Urea Breath Test (UBT) 14.3.4. Endoscopy Test Types 14.4. Middle East & Africa Market Value Forecast, by Test Method, 2023-2033 14.4.1. Laboratory-based Tests 14.4.2. Point-of-Care Tests 14.5. Middle East & Africa Market Value Forecast, by End-user, 2023-2033 14.5.1. Hospitals 14.5.2. Clinics 14.5.3. Diagnostic Laboratories 14.6. Middle East & Africa Market Attractiveness Analysis 14.6.1. By Country/Sub-region 14.6.2. By Test Type 14.6.3. By Test Method 14.6.4. By End-user 15. Competitive Landscape 15.1. Competition Matrix 15.2. Market Share Analysis, by Company, 2018 15.3. Company Profiles 15.3.1. DiaSorin S.p.A. 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.1.2. Financial Overview 15.3.1.3. Test Type Portfolio 15.3.1.4. SWOT Analysis 15.3.1.5. Strategic Overview 15.3.2. Meridian Bioscience, Inc. 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2.2. Financial Overview 15.3.2.3. Test Type Portfolio 15.3.2.4. SWOT Analysis 15.3.2.5. Strategic Overview 15.3.3. Exalenz Bioscience Ltd. 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.3.2. Financial Overview 15.3.3.3. Test Type Portfolio 15.3.3.4. SWOT Analysis 15.3.3.5. Strategic Overview 15.3.4. Alere 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.4.2. Financial Overview 15.3.4.3. Test Type Portfolio 15.3.4.4. SWOT Analysis 15.3.4.5. Strategic Overview 15.3.5. Thermo Fisher Scientific 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.5.2. Financial Overview 15.3.5.3. Test Type Portfolio 15.3.5.4. SWOT Analysis 15.3.5.5. Strategic Overview 15.3.6. Biomerica, Inc. 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.6.2. Financial Overview 15.3.6.3. Test Type Portfolio 15.3.6.4. SWOT Analysis 15.3.6.5. Strategic Overview 15.3.7. Certest Biotec S.L. 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.7.2. Financial Overview 15.3.7.3. Test Type Portfolio 15.3.7.4. SWOT Analysis 15.3.7.5. Strategic Overview 15.3.8. Sekisui Diagnostics 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.8.2. Financial Overview 15.3.8.3. Test Type Portfolio 15.3.8.4. SWOT Analysis 15.3.8.5. Strategic Overview 15.3.9. CorisBioconcept SPRL 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.9.2. Financial Overview 15.3.9.3. Test Type Portfolio 15.3.9.4. SWOT Analysis 15.3.9.5. Strategic Overview 15.3.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.10.2. Financial Overview 15.3.10.3. Test Type Portfolio 15.3.10.4. SWOT Analysis 15.3.10.5. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
Table 02: Global Market Value (US$ Mn) Forecast, by Test Method, 2023–2033
Table 03: Global Market Value (US$ Mn) Forecast, by End User, 2023–2033
Table 04: Global Market Value (US$ Mn) Forecast, by Region, 2023–2033
Table 05: North America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 06: North America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
Table 07: North America Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
Table 08: North America Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
Table 09: Europe Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 10: Europe Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
Table 11: Europe Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
Table 12: Europe Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
Table 13: Asia Pacific Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 14: Asia Pacific Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
Table 15: Asia Pacific Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
Table 16: Asia Pacific Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
Table 17: Latin America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 18: Latin America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
Table 19: Latin America Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
Table 20: Latin America Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
Table 21: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Country, 2023–2033
Table 22: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033
Table 23: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033
Table 24: Middle East & Africa Market Revenue (US$ Mn) Forecast, by End User, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Prevalence of Helicobacter Pylori, North America, 2022
Figure 02: Prevalence of Helicobacter Pylori, Europe, 2022
Figure 03: Prevalence of Helicobacter Pylori, Asia Pacific, 2022
Figure 04: Prevalence of Helicobacter Pylori, Latin America, 2022
Figure 05: Prevalence of Helicobacter Pylori, Middle East & Africa, 2022
Figure 06: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, 2023–2033
Figure 07: Opportunity Map, by Non-invasive Test Type and Test Method, 2022
Figure 08: Opportunity Map, by End User, 2022
Figure 09: Global Market Value Share, by Region (2022)
Figure 10: Global Market Value Share, by Test Method (2022)
Figure 11: Global Market Value Share, by Non-Invasive Test Type (2022)
Figure 12: Global Market Value Share, by End-user (2022)
Figure 13: Global Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 14: Global Market Revenue (US$ Mn), by Serology Test, 2023–2033
Figure 15: Global Market Revenue (US$ Mn), by SAT, 2023–2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by UBT, 2023–2033
Figure 17: Global Market Attractiveness, by Non-invasive Test Type, 2023–2033
Figure 18: Global Market Value Share, by Test Method, 2020 and 2026
Figure 19: Global Market Attractiveness, by Test Method, 2023–2033
Figure 20: Global Market Revenue (US$ Mn), by Laboratory Based Tests, 2023–2033
Figure 21: Global Market Revenue (US$ Mn), by Point-of-Care Tests, 2023–2033
Figure 22: Global Market Value Share, by End User, 2020 and 2026
Figure 23: Global Market Attractiveness, by End User, 2023–2033
Figure 24: Global Market Revenue (US$ Mn), by Hospitals, 2023–2033
Figure 25: Global Market Revenue (US$ Mn), by Clinics, 2023–2033
Figure 26: Global Market Revenue (US$ Mn), by Diagnostic Labs, 2023–2033
Figure 27: Global Market Value Share (%), by Region, 2020 and 2026
Figure 28: Global Market Attractiveness, by Region, 2023–2033
Figure 29: North America Market Value Share, by Country, 2020 and 2026
Figure 30: North America Market Attractiveness, by Country, 2023–2033
Figure 31: North America Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 32: North America Market Attractiveness, by Non-invasive Test Type, 2023–2033
Figure 33: North America Market Value Share, by Test Method, 2020 and 2026
Figure 34: North America Market Attractiveness, by Test Method, 2023–2033
Figure 35: North America Market Value Share, by End User, 2020 and 2026
Figure 36: North America Market Attractiveness, by End User, 2023–2033
Figure 37: Europe Market Value Share, by Country, 2020 and 2026
Figure 38: Europe Market Attractiveness, by Country, 2023–2033
Figure 39: Europe Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 40: Europe Market Attractiveness, by Non-invasive Test Type, 2023–2033
Figure 41: Europe Market Value Share, by Test Method, 2020 and 2026
Figure 42: Europe Market Attractiveness, by Test Method, 2023–2033
Figure 43: Europe Market Value Share, by End User, 2020 and 2026
Figure 44: Europe Market Attractiveness, by End User, 2023–2033
Figure 45: Asia Pacific Market Value Share, by Country, 2020 and 2026
Figure 46: Asia Pacific Market Attractiveness, by Country, 2023–2033
Figure 47: Asia Pacific Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 48: Asia Pacific Market Attractiveness, by Non-invasive Test Type, 2023–2033
Figure 49: Asia Pacific Market Value Share, by Test Method, 2020 and 2026
Figure 50: Asia Pacific Market Attractiveness, by Test Method, 2023–2033
Figure 51: Asia Pacific Market Value Share, by End User, 2020 and 2026
Figure 52: Asia Pacific Market Attractiveness, by End User, 2023–2033
Figure 53: Latin America Market Value Share, by Country, 2020 and 2026
Figure 54: Latin America Market Attractiveness, by Country, 2023–2033
Figure 55: Latin America Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 56: Latin America Market Attractiveness, by Non-invasive Test Type, 2023–2033
Figure 57: Latin America Market Value Share, by Test Method, 2020 and 2026
Figure 58: Latin America Market Attractiveness, by Test Method, 2023–2033
Figure 59: Latin America Market Value Share, by End User, 2020 and 2026
Figure 60: Latin America Market Attractiveness, by End User, 2023–2033
Figure 61: Middle East & Africa Market Value Share, by Country, 2020 and 2026
Figure 62: Middle East & Africa Market Attractiveness, by Country, 2023–2033
Figure 63: Middle East & Africa Market Value Share, by Non-invasive Test Type, 2020 and 2026
Figure 64: Middle East & Africa Market Attractiveness, by Non-invasive Test Type, 2023–2033
Figure 65: Middle East & Africa Market Value Share, by Test Method, 2020 and 2026
Figure 66: Middle East & Africa Market Attractiveness, by Test Method, 2023–2033
Figure 67: Middle East & Africa Market Value Share, by End User, 2020 and 2026
Figure 68: Middle East & Africa Market Attractiveness, by End User, 2023–2033
Figure 69: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing, Company Share Analysis, 2022 (Estimated)
Figure 70: DiaSorin S.p.A Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Figure 71: DiaSorin S.p.A Breakdown of Net Sales (%), by Region, 2022
Figure 72: Meridian Bioscience, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Figure 73: Meridian Bioscience, Inc. Breakdown of Net Sales (%), by Business Segment, 2022
Figure 74: Exalenz Bioscience Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Figure 75: Exalenz Bioscience Ltd. R&D Expenditure (US$ Mn), 2018-2022
Figure 76: Alere (Abbott) Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Figure 77: Alere (Abbott) Breakdown of Net Sales (%), by Business Segment, 2022
Figure 78: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Figure 79: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request